Integrated Biosciences Announces Nature Publication Identifying New Class of Antibiotics Discovered Via Company’s AI-Powered Platform

SAN CARLOS, Calif.–(BUSINESS WIRE)– #AI–Integrated Biosciences, a biotechnology company pioneering the use of synthetic biology and machine learning to develop next-generation therapeutics for age-related diseases, today announced the publication in the journal Nature of a peer-reviewed manuscript detailing the application of its platform in the discovery of a new class…
Click here to view original post

Advertisement — Advertise with Biotech Networks